The prevalence of large-scale chronic inflammation in SCD pathology and role of NLRP3 in various pathological events like vascular occlusion, platelet aggregation, and thrombosis warrants the exploration of translating this data to human studies for better management of SCD. This evidence concerns the gene NLRP3 and Schnyder corneal dystrophy.